Please complete the CAPTCHA to continue
@bioaccel.org
✓
3 phones found area 602
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Anthony Bajoras is listed as Founder & Managing Director at CANCER FUND at CANCER FUND, based in Greater Phoenix Area, United States, United States. AeroLeads shows a work email signal at bioaccel.org, phone signal with area code 602, and a matched LinkedIn profile for Anthony Bajoras.
Anthony Bajoras previously worked as Founder & Managing Director at Cancer Fund and Investor at Nxgenport. Anthony Bajoras holds Non-Degree Graduate Studies, Engineering & Project Management from Northwestern University.
This section adds company-level context without repeating Anthony Bajoras's masked contact details.
AeroLeads found 1 current-domain work email signal for Anthony Bajoras. Compare company email patterns before reaching out.
As Managing Director of CANCER FUND, I lead a community of impact investors supporting early-stage companies developing and commercializing innovations aiming to improve outcomes for cancer patients, survivors, previvors, and the people who care for them.
Listed skills include Digital Marketing, Strategic Partnerships, Analytics, Start Ups, and 44 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Phoenix, Arizona, US
CANCER FUND is a community of impact investors. We invest in early-stage companies advancing cancer innovations beyond research and through development to improve outcomes for patients, survivors, and previvors. CANCER FUND makes investing in cancer innovation fast, easy, and affordable. Learn more at www.CancerFund.comSECURITIES DISCLAIMER: Cancer Fund.
Saint Paul, MN, US
CANCER FUND invested in NXgenPort because of its potential to revolutionize cancer care through innovative technology. By integrating real-time remote monitoring with a proven implantable port design, NXgenPort aims to address critical gaps in managing chemotherapy for patients and their physicians. Detecting life-threatening conditions early could reduce.
CANCER FUND invested in Veana Therapeutics to support the development of novel treatments for breast and other cancers. Veana is a clinical-stage biopharmaceutical company currently examining the use of its lead compound, VT-101, in a clinical trial of women with intractable breast cancer. VT-101 works by destabilizing mitochondria (the powerhouse of.
Pasadena, California, US
Early data show that Avesta76’s targeted therapeutics offer promise for multiple cancers of interest to our investor community, including chemo-resistant ovarian cancer, breast cancer (specifically Triple Negative Breast Cancer), and colorectal cancer among others. Forty years and three generations of the same family have culminated in a novel targeted.
Denver, CO, US
Ovarian cancer is among the most deadly cancer types. Diagnosis is commonly made at later stages where treatment options are limited, leading to a 5-year survival rate of only 28%. AOA’s innovative test offers the promise of earlier detection of Ovarian cancer when symptoms first present, and early detection saves lives. As an impact investment, CANCER.
South Bend, Indiana, US
NearWave holds promise as a potential breakthrough improvement in breast cancer diagnosis and treatment. Their novel handheld clinical device uses imaging technology to monitor patient response to neoadjuvant chemotherapy, which is the first line of treatment in stage IIB breast cancer patients. The system’s ease of use in the clinic and relative.
Tucson, Arizona, US
Reglagene is creating new drug treatments to effectively reach and treat the brain. Their leading product, RGN6024, is a major advancement in treating brain cancers. This drug works by targeting a key process in cancer cells, making it a powerful weapon against the disease. It's taken orally, easy on the body, and has an exceptional ability to reach the.
Phoenix, Arizona
CXO provides advisory, governance, and interim management to venture capital funds and ventures commercializing technologies and solutions for heath, wellness, and well-being. CXO’s partners are proven venture capitalists, entrepreneurs, and executives applying their experience to help clients through ideation, innovation, incubation, and acceleration.
Quick answers generated from the profile data available on this page.
Anthony Bajoras works for CANCER FUND.
Anthony Bajoras is listed as Founder & Managing Director at CANCER FUND at CANCER FUND.
AeroLeads has found 1 work email signal at @bioaccel.org for Anthony Bajoras at CANCER FUND.
AeroLeads has found 3 phone signal(s) with area code 602 for Anthony Bajoras at CANCER FUND.
Anthony Bajoras is based in Greater Phoenix Area, United States, United States while working with CANCER FUND.
Anthony Bajoras has worked for Cancer Fund, Nxgenport, Veana Therapeutics, Inc., Avesta76 Therapeutics, and Aoa Dx.
You can use AeroLeads to view verified contact signals for Anthony Bajoras at CANCER FUND, including work email, phone, and LinkedIn data when available.
Anthony Bajoras holds Non-Degree Graduate Studies, Engineering & Project Management from Northwestern University.
Anthony Bajoras is listed with skills including Digital Marketing, Strategic Partnerships, Analytics, Start Ups, Marketing Strategy, Strategy, Online Marketing, and Marketing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts